Quantum Biopharma Ltd. Files 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Oct 20, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Oct 20, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting-update, sec-filing, foreign-private-issuer
TL;DR
Quantum Biopharma (fka FSD Pharma) filed a 6-K, confirming 20-F annual report filings.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 20, 2025. The company, incorporated in A6 with its principal executive office in Toronto, Ontario, is reporting as a foreign private issuer. This filing indicates they will file annual reports under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's reporting status and confirms their adherence to SEC regulations for foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming reporting status and not indicating any new financial or operational developments.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the 6-K report
- FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
- October 20, 2025 (date) — Filing date of the 6-K report
- Form 20-F (document) — Annual report form Quantum Biopharma Ltd. will file
- Form 6-K (document) — Type of report filed
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report as a foreign private issuer and indicate that the registrant files or will file annual reports under cover of Form 20-F.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd.'s principal executive office located?
The principal executive office is located at 1 Adelaide Street East, Suite 801, Toronto, Ontario M5C 2V9.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code is 2834, Pharmaceutical Preparations.
Does Quantum Biopharma Ltd. file its annual reports on Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates it files or will file annual reports under cover of Form 20-F.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2025-10-20 08:30:07
Filing Documents
- f6k_101925.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 10KB
- 0001171843-25-006520.txt ( ) — 17KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: October 20, 2025 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated October 20, 2025